clinical trial

(WWJ Photo, File)

DMC First in Michigan to Participate in Clinical Trial for Treating Heart Failure

In an effort toward the research and development of new and potentially breakthrough treatment options for patients with congestive heart failure, DMC Cardiovascular Institute has become the first hospital in Michigan and the seventh hospital across the United States to participate in the INOVATE-HF (INcrease Of VAgal TonE Heart Failure) clinical trial.

WWJ Newsradio 950–03/27/2012

Henry Ford Hospital. Photo by Mikerussell at Wikimedia Commons

Henry Ford Pioneering New Treatment For Aggressive Brain Tumors

Henry Ford Hospital’s Hermelin Brain Tumor Center is the first U.S. hospital to start a new clinical trial for Toca 511 & Toca FC, a combination therapy under investigation for high-grade glioma, a fast-growing brain cancer that often recurs even after surgery, radiation treatment and chemotherapy.

WWJ Newsradio 950–01/31/2012


Adeona Starts Phase II Trials Of New MS Drug

Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had started a Phase II clinical trial of Trimesta (oral estriol) for the treatment of cognitive dysfunction in multiple sclerosis in women.

WWJ Newsradio 950–01/19/2012


CytoPherx Raises $34M To Move Into U.S. Clinical Trials

CytoPherx Inc. announced it has completed a $34 million round of funding. The funds will be used to complete United States clinical trials and gain FDA approval to commercialize the CytoPherx anti-inflammatory therapy for acute kidney injury.

WWJ Newsradio 950–01/04/2012


Adeona Completes Enrollment In Phase II Trial Of MS Drug

Adeona Pharmaceuticals Inc. said Monday that the 150th patient has been enrolled in the randomized, double-blind, placebo-controlled, multi-center clinical trial of its Trimesta oral estriol drug candidate for relapsing-remitting multiple sclerosis in women.

WWJ Newsradio 950–09/19/2011

Spectrum Health Participating In Heart Valve Clinical Trial

Grand Rapids-based Spectrum Health is participating in a clinical trial to evaluate a transcatheter alternative to open-heart surgery for patients with severe aortic stenosis.

WWJ Newsradio 950–08/07/2011


NanoBio: First Patients Vaccinated In Phase 1B Nasal Flu Vaccine Study

Building upon a series of successful preclinical and clinical studies, Ann Arbor-based NanoBio Corp. Tuesday announced the initiation of a second tolerability and immunogenicity study designed to test and further optimize its novel nanoemulsion-based intranasal vaccine adjuvant.

WWJ Newsradio 950–06/21/2011

Pfizer Thelin Withdrawal

Michigan Part Of Pfizer Virtual Clinical Trial

Michigan is one of 10 states where the 600 patients are being drawn from for Pfizer Inc.’s first-ever virtual clinical trial. The trial model allows patients to participate regardless of geography.

WWJ Newsradio 950–06/08/2011


Battle Creek Surgery Center Hosting Trial Of Partial Knee Implant

Battle Creek-based Brookside Surgery Center said one of its surgeons, Joseph Burkhardt, is participating in a 10-year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee

WWJ Newsradio 950–04/26/2011

metabolic solutions

Metabolic Solutions Launches New Trial Of Diabetes Drug

Kalamazoo-based Metabolic Solutions Development Co., a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced Tuesday that it has launched a Phase 2a trial for MSDC-0602, the company’s second drug candidate for the treatment of type 2 diabetes.